BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36266600)

  • 1. Immuno-PET Monitoring of CD8
    Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
    Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of
    Maresca KP; Chen J; Mathur D; Giddabasappa A; Root A; Narula J; King L; Schaer D; Golas J; Kobylarz K; Rosfjord E; Keliher E; Chen L; Ram S; Pickering EH; Hardwick JS; Rejto PA; Hussein A; Ilovich O; Staton K; Wilson I; McCarthy TJ
    Mol Imaging Biol; 2021 Dec; 23(6):941-951. PubMed ID: 34143379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PET-Tracer
    Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
    Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of
    Farwell MD; Gamache RF; Babazada H; Hellmann MD; Harding JJ; Korn R; Mascioni A; Le W; Wilson I; Gordon MS; Wu AM; Ulaner GA; Wolchok JD; Postow MA; Pandit-Taskar N
    J Nucl Med; 2022 May; 63(5):720-726. PubMed ID: 34413145
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jung KH; Lee JH; Kim M; Cho YS; Lee KH
    Mol Imaging; 2022; 2022():5916692. PubMed ID: 35250391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade.
    Rashidian M; LaFleur MW; Verschoor VL; Dongre A; Zhang Y; Nguyen TH; Kolifrath S; Aref AR; Lau CJ; Paweletz CP; Bu X; Freeman GJ; Barrasa MI; Weinberg RA; Sharpe AH; Ploegh HL
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16971-16980. PubMed ID: 31375632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-Humans Imaging with
    Pandit-Taskar N; Postow MA; Hellmann MD; Harding JJ; Barker CA; O'Donoghue JA; Ziolkowska M; Ruan S; Lyashchenko SK; Tsai F; Farwell M; Mitchell TC; Korn R; Le W; Lewis JS; Weber WA; Behera D; Wilson I; Gordon M; Wu AM; Wolchok JD
    J Nucl Med; 2020 Apr; 61(4):512-519. PubMed ID: 31586002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of
    Bouleau A; Nozach H; Dubois S; Kereselidze D; Chevaleyre C; Wang CI; Evans MJ; Lebon V; Maillère B; Truillet C
    J Nucl Med; 2022 Aug; 63(8):1259-1265. PubMed ID: 34933891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET.
    Simonetta F; Alam IS; Lohmeyer JK; Sahaf B; Good Z; Chen W; Xiao Z; Hirai T; Scheller L; Engels P; Vermesh O; Robinson E; Haywood T; Sathirachinda A; Baker J; Malipatlolla MB; Schultz LM; Spiegel JY; Lee JT; Miklos DB; Mackall CL; Gambhir SS; Negrin RS
    Clin Cancer Res; 2021 Feb; 27(4):1058-1068. PubMed ID: 33087332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Gallegos CA; Lu Y; Clements JC; Song PN; Lynch SE; Mascioni A; Jia F; Hartman YE; Massicano AVF; Houson HA; Lapi SE; Warram JM; Markert JM; Sorace AG
    Theranostics; 2024; 14(3):911-923. PubMed ID: 38250045
    [No Abstract]   [Full Text] [Related]  

  • 12. Cysteine-specific
    Lee JH; Jung KH; Kim M; Lee KH
    Front Immunol; 2022; 13():1017132. PubMed ID: 36591250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel [
    Puyalto A; Rodríguez-Remírez M; López I; Iribarren F; Simón JA; Ecay M; Collantes M; Vilalta-Lacarra A; Francisco-Cruz A; Solórzano JL; Sandiego S; Peñuelas I; Calvo A; Ajona D; Gil-Bazo I
    Front Immunol; 2023; 14():1272570. PubMed ID: 37841258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of
    Kol A; Fan X; Wazynska MA; van Duijnhoven SMJ; Giesen D; Plat A; Van Eenennaam H; Elsinga PH; Nijman HW; de Bruyn M
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical PET imaging with the novel human antibody
    Kelly MP; Makonnen S; Hickey C; Arnold TC; Giurleo JT; Tavaré R; Danton M; Granados C; Chatterjee I; Dudgeon D; Retter MW; Ma D; Olson WC; Thurston G; Kirshner JR
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.
    Rashidian M; Ingram JR; Dougan M; Dongre A; Whang KA; LeGall C; Cragnolini JJ; Bierie B; Gostissa M; Gorman J; Grotenbreg GM; Bhan A; Weinberg RA; Ploegh HL
    J Exp Med; 2017 Aug; 214(8):2243-2255. PubMed ID: 28666979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-PET imaging of tumor endothelial marker 8 (TEM8).
    Kuo F; Histed S; Xu B; Bhadrasetty V; Szajek LP; Williams MR; Wong K; Wu H; Lane K; Coble V; Vasalatiy O; Griffiths GL; Paik CH; Elbuluk O; Szot C; Chaudhary A; St Croix B; Choyke P; Jagoda EM
    Mol Pharm; 2014 Nov; 11(11):3996-4006. PubMed ID: 24984190
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    van der Veen EL; Giesen D; Pot-de Jong L; Jorritsma-Smit A; De Vries EGE; Lub-de Hooge MN
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT Imaging of
    Li W; Wang Y; Rubins D; Bennacef I; Holahan M; Haley H; Purcell M; Gantert L; Hseih S; Judo M; Seghezzi W; Zhang S; van der Veen EL; Lub-de Hooge MN; de Vries EGE; Evelhoch JL; Klimas M; Hostetler ED
    Mol Imaging Biol; 2021 Apr; 23(2):250-259. PubMed ID: 33104972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody.
    Christensen C; Kristensen LK; Alfsen MZ; Nielsen CH; Kjaer A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1302-1313. PubMed ID: 31883023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.